Medicaid Rebate Ceiling Raised To 125% In Senate Legislation

Senate Finance Committee's drug pricing bill would also exclude authorized generics from calculation of average manufacturer prices and rebates and authorize installment-type payments for curative gene therapies.

rebates road sign illustration design over a white background - Illustration
Manufacturers Could Pay Medicaid For Using Their Drugs In Some Cases

The maximum allowable prescription drug rebate in Medicaid is raised from 100% of the price to 125% in legislation announced 23 July by the Senate Finance Committee.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Pricing Debate

More from Market Access